Verona Pharma Stock Forecast

Stock Price Forecast

The 8 analysts that cover Verona Pharma stock have a consensus rating of "Strong Buy" and an average price target of $105.38, which forecasts a 12.32% increase in the stock price over the next year. The lowest target is $57 and the highest is $160.

Price Target: $105.38 (+12.32%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$57	$105.38	$110	$160
Change	-39.25%	+12.32%	+17.25%	+70.54%

Analyst Ratings

The average analyst rating for Verona Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	5
Buy	3	3	3	1	1	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	5	5	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $76 → $160	Buy	Maintains	$76 → $160	+70.54%	Jun 23, 2025
Tiago Fauth Wells Fargo	Wells Fargo	Buy Maintains $107 → $138	Buy	Maintains	$107 → $138	+47.09%	Jun 20, 2025
Boobalan Pachaiyappan Roth Capital	Roth Capital	Strong Buy Reiterates $92 → $116	Strong Buy	Reiterates	$92 → $116	+23.64%	Jun 18, 2025
Andrew Tsai Jefferies	Jefferies	Strong Buy Maintains $95 → $110	Strong Buy	Maintains	$95 → $110	+17.25%	Jun 11, 2025
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $90 → $100	Buy	Maintains	$90 → $100	+6.59%	Jun 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

419.32M

from 42.28M

891.79%

from 42.28M

Revenue Next Year

750.33M

from 419.32M

78.94%

from 419.32M

EPS This Year

0.05

from -2.16

EPS Next Year

1.50

from 0.05

2,833.34%

from 0.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	40.00M	458.00K	-	42.28M	419.32M	750.33M	989.13M
Revenue Growth	-	-	-98.86%	-	-	891.79%	78.94%	31.83%
EPS	-1.98	-0.94	-1.04	-0.72	-2.16	0.05	1.50	3.07
EPS Growth	-	-	-	-	-	-	2,833.34%	104.89%
Forward PE	-	-	-	-	-	1,839.61	62.71	30.61
No. Analysts	-	-	-	-	-	11	10	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	474.7M	943.3M	1.3B
Avg	419.3M	750.3M	989.1M
Low	361.7M	560.4M	747.1M

Revenue Growth

Revenue Growth	2025	2026	2027
High	1,022.8%	125.0%	68.5%
Avg	891.8%	78.9%	31.8%
Low	755.5%	33.7%	-0.4%

EPS Forecast

EPS	2025	2026	2027
High	0.17	3.98	4.76
Avg	0.05	1.50	3.07
Low	-0.11	0.37	0.46

EPS Growth

EPS Growth	2025	2026	2027
High	-	7,702.9%	217.9%
Avg	-	2,833.3%	104.9%
Low	-	630.2%	-69.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.